Roche Diagnostics Operations, Inc

Form 483 issued August 15, 2016 · Indianapolis, Indiana

Inspection
Aug 4 – Aug 15, 2016
Observations
1
Pages
3
FEI number
1823260

In short: On August 15, 2016, FDA issued a Form 483 with 1 observation to Roche Diagnostics Operations, Inc in Indianapolis, Indiana (FEI 1823260) after an inspection that ran Aug 4 – Aug 15, 2016. The investigators were Joseph R. Strelnik and Kennita Riddick. Most observations concern cAPA; the most-cited regulation is 21 CFR 806.10 (reports of corrections and removals).

At a glance

1 of 1 observations on this 483 concern capa.

CAPA1

Most cited: 21 CFR 806.10(a)(1) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    A correction or removal, conducted to reduce a risk to health posed by a device, was…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Roche Diagnostics Operations, Inc?

FDA listed 1 observation on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 806.10 (reports of corrections and removals). The opening words of each observation are shown on this page.

Who inspected Roche Diagnostics Operations, Inc?

Joseph R. Strelnik and Kennita Riddick are named on this Form 483, for the inspection of Aug 4 – Aug 15, 2016. Each investigator has a profile showing what they cite most.

When was Roche Diagnostics Operations, Inc inspected by FDA?

The inspection ran Aug 4 – Aug 15, 2016, and the Form 483 is dated August 15, 2016.

How do I get the full Form 483 for Roche Diagnostics Operations, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free